Clinical Trial Update: Romosozumab in Women With Chronic SCI [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating romosozumab for osteoporosis in women with chronic spinal cord injury has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteopenia
• Osteoporosis
• Spinal Cord Injury

Drugs mentioned

• Evenity (romosozumab)

Snippet

Sponsor: Northwestern University | Conditions: Osteoporosis, Bone Loss | Phase 2 | Status: COMPLETED | Results posted: 2025-09-24